Competitive inhibition of cell binding induced by B5V60 towards anti-STn antibody could be useful in STn-based targeting of cancer cells as a drug delivery system as well as in enhancing immune responses against immunotolerant tumor cells highly expressing STn. Here, EEF1A2 is linked to neoplasm.